Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Gross Profit 2010-2024 | MKKGY

Merck annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Merck gross profit for the quarter ending September 30, 2024 was $3.457B, a 5.49% increase year-over-year.
  • Merck gross profit for the twelve months ending September 30, 2024 was $13.329B, a 3.13% decline year-over-year.
  • Merck annual gross profit for 2023 was $13.413B, a 7.11% decline from 2022.
  • Merck annual gross profit for 2022 was $14.44B, a 1.06% decline from 2021.
  • Merck annual gross profit for 2021 was $14.595B, a 19.42% increase from 2020.
  
Merck Annual Gross Profit
(Millions of US $)
2023 $13,413
2022 $14,440
2021 $14,595
2020 $12,221
2019 $11,364
2018 $11,165
2017 $11,311
2016 $10,870
2015 $9,730
2014 $10,600
2013 $10,763
2012 $10,308
2011 $9,915
2010 $12,338
2009 $10,807
Merck Quarterly Gross Profit
(Millions of US $)
2024-09-30 $3,457
2024-06-30 $3,482
2024-03-31 $3,267
2023-12-31 $3,123
2023-09-30 $3,277
2023-06-30 $3,449
2023-03-31 $3,564
2022-12-31 $3,470
2022-09-30 $3,685
2022-06-30 $3,681
2022-03-31 $3,603
2021-12-31 $3,731
2021-09-30 $3,672
2021-06-30 $3,683
2021-03-31 $3,508
2020-12-31 $3,340
2020-09-30 $3,122
2020-06-30 $2,763
2020-03-31 $2,996
2019-12-31 $2,987
2019-09-30 $2,865
2019-06-30 $2,829
2019-03-31 $2,683
2018-12-31 $2,601
2018-09-30 $2,796
2018-06-30 $2,854
2018-03-31 $2,914
2017-12-31 $2,908
2017-09-30 $2,854
2017-06-30 $2,816
2017-03-31 $2,734
2016-12-31 $2,696
2016-09-30 $2,760
2016-06-30 $2,813
2016-03-31 $2,601
2015-12-31 $2,537
2015-09-30 $2,444
2015-06-30 $2,437
2015-03-31 $2,366
2014-12-31 $2,114
2014-09-30 $2,638
2014-06-30 $2,690
2014-03-31 $2,644
2013-12-31 $2,672
2013-09-30 $2,687
2013-06-30 $2,767
2013-03-31 $2,625
2012-12-31 $3,646
2012-09-30 $2,570
2012-06-30 $2,482
2012-03-31 $3,274
2011-12-31 $3,311
2011-09-30 $3,585
2011-06-30 $2,583
2011-03-31 $3,505
2010-12-31 $3,707
2010-09-30 $2,345
2010-06-30 $2,695
2010-03-31 $2,791
2009-12-31 $2,983
2009-09-30 $2,778
2009-06-30 $2,590
2009-03-31 $2,456
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $18.882B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $73.684B 28.35
Chugai Pharmaceutical (CHGCY) Japan $69.441B 27.05
Takeda Pharmaceutical (TAK) Japan $41.205B 8.58
Sandoz Group AG (SDZNY) Switzerland $18.766B 0.00
Astellas Pharma (ALPMY) Japan $17.138B 15.78
United Therapeutics (UTHR) United States $16.294B 16.03
Neurocrine Biosciences (NBIX) United States $14.266B 37.77
Summit Therapeutics (SMMT) United States $13.163B 0.00
Shionogi (SGIOY) Japan $12.012B 12.03
Madrigal Pharmaceuticals (MDGL) United States $7.392B 0.00
Orion OYJ (ORINY) Finland $6.424B 18.06
Ionis Pharmaceuticals (IONS) United States $5.283B 0.00
Corcept Therapeutics (CORT) United States $5.223B 39.56
Grifols, S.A (GRFS) Spain $5.012B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.764B 0.00
PTC Therapeutics (PTCT) United States $3.389B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.688B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.614B 11.85
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.469B 14.76
NewAmsterdam Pharma (NAMS) Netherlands $2.305B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.062B 0.00
Soleno Therapeutics (SLNO) United States $1.859B 0.00
Indivior (INDV) United States $1.634B 6.66
Dyne Therapeutics (DYN) United States $1.615B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.589B 0.00
Evotec AG (EVO) Germany $1.545B 0.00
Xencor (XNCR) United States $1.442B 0.00
Harrow (HROW) United States $1.306B 0.00
Ocular Therapeutix (OCUL) United States $1.291B 0.00
Guardian Pharmacy Services (GRDN) United States $1.266B 0.00
Ardelyx (ARDX) United States $1.201B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.155B 0.00
ARS Pharmaceuticals (SPRY) United States $1.092B 0.00
Enliven Therapeutics (ELVN) United States $1.062B 0.00
Collegium Pharmaceutical (COLL) United States $1.061B 5.79
Avadel Pharmaceuticals (AVDL) Ireland $0.761B 0.00
Cronos Group (CRON) Canada $0.757B 0.00
Bioventus (BVS) United States $0.753B 23.79
Relay Therapeutics (RLAY) United States $0.745B 0.00
USANA Health Sciences (USNA) United States $0.646B 11.97
Ironwood Pharmaceuticals (IRWD) United States $0.634B 0.00
Oruka Therapeutics (ORKA) United States $0.550B 0.00
Elite Pharmaceuticals (ELTP) United States $0.534B 0.00
Xeris Biopharma Holdings (XERS) United States $0.507B 0.00
Tourmaline Bio (TRML) United States $0.505B 0.00
Altimmune (ALT) United States $0.489B 0.00
OmniAb (OABI) United States $0.486B 0.00
Savara (SVRA) United States $0.477B 0.00
ProKidney (PROK) United States $0.472B 0.00
Verve Therapeutics (VERV) United States $0.468B 0.00
Esperion Therapeutics (ESPR) United States $0.461B 0.00
Siga Technologies (SIGA) United States $0.443B 5.17
Zevra Therapeutics (ZVRA) United States $0.433B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.432B 0.00
KalVista Pharmaceuticals (KALV) United States $0.388B 0.00
Akebia Therapeutics (AKBA) United States $0.382B 0.00
Organogenesis (ORGO) United States $0.378B 0.00
Korro Bio (KRRO) United States $0.330B 0.00
Aldeyra Therapeutics (ALDX) United States $0.294B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.286B 116.07
Jupiter Neurosciences (JUNS) United States $0.283B 0.00
Aquestive Therapeutics (AQST) United States $0.281B 0.00
Nature's Sunshine Products (NATR) United States $0.263B 15.63
4D Molecular Therapeutics (FDMT) United States $0.255B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.240B 0.00
Avita Medical (RCEL) United States $0.240B 0.00
Heron Therapeutics (HRTX) United States $0.236B 0.00
Larimar Therapeutics (LRMR) United States $0.234B 0.00
Profound Medical (PROF) Canada $0.227B 0.00
Lexeo Therapeutics (LXEO) United States $0.211B 0.00
Inhibikase Therapeutics (IKT) United States $0.198B 0.00
Nektar Therapeutics (NKTR) United States $0.190B 0.00
CytoDyn (CYDY) United States $0.183B 0.00
MediWound (MDWD) Israel $0.180B 0.00
VAXART, INC (VXRT) United States $0.180B 0.00
Silence Therapeutics (SLN) United Kingdom $0.179B 0.00
Lyell Immunopharma (LYEL) United States $0.176B 0.00
Aclaris Therapeutics (ACRS) United States $0.176B 0.00
Acrivon Therapeutics (ACRV) United States $0.170B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.144B 0.00
Cassava Sciences (SAVA) United States $0.136B 0.00
Nanobiotix S.A (NBTX) France $0.133B 0.00
Champions Oncology (CSBR) United States $0.131B 0.00
Telomir Pharmaceuticals (TELO) United States $0.122B 0.00
Metagenomi (MGX) United States $0.117B 0.00
Achieve Life Sciences (ACHV) Canada $0.116B 0.00
Protara Therapeutics (TARA) United States $0.115B 0.00
Inotiv (NOTV) United States $0.114B 0.00
ElectroCore (ECOR) United States $0.108B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.108B 0.00
Cardiol Therapeutics (CRDL) Canada $0.105B 0.00
Regulus Therapeutics (RGLS) United States $0.092B 0.00
Pyxis Oncology (PYXS) United States $0.092B 0.00
Karyopharm Therapeutics (KPTI) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.089B 0.00
Arch Biopartners (ACHFF) Canada $0.087B 0.00
Century Therapeutics (IPSC) United States $0.084B 0.00
Context Therapeutics (CNTX) United States $0.081B 0.00
Journey Medical (DERM) United States $0.080B 0.00
Assertio Holdings (ASRT) United States $0.080B 20.91
ESSA Pharma (EPIX) Canada $0.077B 0.00
PMV Pharmaceuticals (PMVP) United States $0.076B 0.00
Avalo Therapeutics (AVTX) United States $0.073B 0.00
Vivani Medical (VANI) United States $0.072B 0.00
Galectin Therapeutics (GALT) United States $0.069B 0.00
Unicycive Therapeutics (UNCY) United States $0.069B 0.00
Mural Oncology (MURA) Ireland $0.066B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.063B 0.00
FibroGen (FGEN) United States $0.062B 0.00
Gain Therapeutics (GANX) United States $0.061B 0.00
AleAnna (ANNA) United States $0.060B 0.00
NRx Pharmaceuticals (NRXP) United States $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.058B 0.00
OptiNose (OPTN) United States $0.053B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.052B 0.00
AlloVir (ALVR) United States $0.051B 0.00
VYNE Therapeutics (VYNE) United States $0.051B 0.00
Rafael Holdings (RFL) United States $0.048B 0.00
SCYNEXIS (SCYX) United States $0.047B 0.00
Nutriband (NTRB) United States $0.046B 0.00
Iterum Therapeutics (ITRM) Ireland $0.045B 0.00
Scienture Holdings (SCNX) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.041B 0.00
CASI Pharmaceuticals (CASI) China $0.040B 0.00
BioVie (BIVI) United States $0.039B 0.00
Surrozen (SRZN) United States $0.036B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.033B 0.00
Incannex Healthcare (IXHL) Australia $0.033B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.030B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.030B 0.00
Mannatech (MTEX) United States $0.028B 0.00
Citius Pharmaceuticals (CTXR) United States $0.028B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.025B 0.00
Vivos Therapeutics (VVOS) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Traws Pharma (TRAW) United States $0.024B 0.00
DURECT (DRRX) United States $0.024B 0.00
Carisma Therapeutics (CARM) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.015B 0.00
PolyPid (PYPD) Israel $0.015B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Relmada Therapeutics (RLMD) United States $0.012B 0.00
Jaguar Animal Health (JAGX) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Klotho Neurosciences (KLTO) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
SciSparc (SPRC) Israel $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.008B 0.00
Viracta Therapeutics (VIRX) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Dominari Holdings (DOMH) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Biomerica (BMRA) United States $0.006B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.10
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
TransCode Therapeutics (RNAZ) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Conduit Pharmaceuticals (CDT) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 44.98